From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:2q3z.jpg|left|200px]] | + | {{Seed}} |
| | + | [[Image:2q3z.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_2q3z| PDB=2q3z | SCENE= }} | | {{STRUCTURE_2q3z| PDB=2q3z | SCENE= }} |
| | | | |
| - | '''Transglutaminase 2 undergoes large conformational change upon activation'''
| + | ===Transglutaminase 2 undergoes large conformational change upon activation=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Human transglutaminase 2 (TG2), a member of a large family of enzymes that catalyze protein crosslinking, plays an important role in the extracellular matrix biology of many tissues and is implicated in the gluten-induced pathogenesis of celiac sprue. Although vertebrate transglutaminases have been studied extensively, thus far all structurally characterized members of this family have been crystallized in conformations with inaccessible active sites. We have trapped human TG2 in complex with an inhibitor that mimics inflammatory gluten peptide substrates and have solved, at 2-A resolution, its x-ray crystal structure. The inhibitor stabilizes TG2 in an extended conformation that is dramatically different from earlier transglutaminase structures. The active site is exposed, revealing that catalysis takes place in a tunnel, bridged by two tryptophan residues that separate acyl-donor from acyl-acceptor and stabilize the tetrahedral reaction intermediates. Site-directed mutagenesis was used to investigate the acyl-acceptor side of the tunnel, yielding mutants with a marked increase in preference for hydrolysis over transamidation. By providing the ability to visualize this activated conformer, our results create a foundation for understanding the catalytic as well as the non-catalytic roles of TG2 in biology, and for dissecting the process by which the autoantibody response to TG2 is induced in celiac sprue patients.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_18092889}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 18092889 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_18092889}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 31: |
Line 35: |
| | [[Category: Transferase]] | | [[Category: Transferase]] |
| | [[Category: Transglutaminase 2]] | | [[Category: Transglutaminase 2]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 14:17:32 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 15:45:35 2008'' |
Revision as of 12:45, 27 July 2008
Template:STRUCTURE 2q3z
Transglutaminase 2 undergoes large conformational change upon activation
Template:ABSTRACT PUBMED 18092889
About this Structure
2Q3Z is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Transglutaminase 2 undergoes a large conformational change upon activation., Pinkas DM, Strop P, Brunger AT, Khosla C, PLoS Biol. 2007 Dec;5(12):e327. PMID:18092889
Page seeded by OCA on Sun Jul 27 15:45:35 2008
